Chemistry of Materials
Article
injection. The solid byproduct is filtered off. The resulting pale yellow
oil is used without further purification. Yield 1.087 g (88%). 31P{1H}
NMR (162 MHz, CDCl3): δ 101.10. 1H NMR (400 MHz, CDCl3): δ
0.73 (t, 6H), 2.48 (s, 6H), 3.02 (m, 4H), 3.39 (oct, 2H), 4.03 (sext,
2H), 7.04 (t, 2H), 7.20 (m, 4H), 7.30 (d, 2H). 13C{1H} NMR (125
MHz, CDCl3): δ 14.30 (s), 19.71 (d), 38.86 (d), 51.55 (d), 123.67
(d), 125.32 (d), 126.45 (s), 131.19 (s). Anal. Calcd for C20H28N3P:
C, 70.36; H, 8.27; N, 12.31. Found: C, 70.46; H, 8.39; N, 12.21. MS
(ASAP) m/z: calcd for [C20H28N3P + H+], 342.2099; found,
342.2104.
N-Octadecyl-1,3-di(2-methylphenyl)-1,3,2-diazaphospholidin-2-
amine (1b). 2-Chloro-1,3-di(2-methylphenyl)-1,3,2-diazaphospholi-
dine (1.106 g, 3.6 mmol), triethylamine (485 mg, 4.80 mmol), and
diethyl ether (15 mL) are loaded into a scintillation vial.
Octadecylamine (1.080 g, 4.000 mmol) is dissolved in diethyl ether
(5 mL) and added dropwise and allowed to stir for 20 min.
Precipitation of a white solid is observed immediately upon injection.
The solid byproduct is filtered off. Volatiles are removed from the
filtrate, and the resulting solid is recrystallized in THF at −40 °C to
yield a pale yellow solid. Yield 1.785 g (91%). 31P{1H} NMR (202
MHz, CDCl3): δ 90.60. 1H NMR (500 MHz, CDCl3): δ 0.91 (t, 3H),
1.28 (m, 34H), 2.35 (m, 1H), 2.47 (s, 6H), 2.90 (quin, 2H), 3.39 (m,
2H), 3.89 (m, 2H), 7.05 (t, 2H), 7.24 (m, 7H). 13C{1H} NMR (125
MHz, CDCl3): δ 14.17 (s), 19.61 (d), 22.73 (s), 26.87 (s), 29.39 (s)
29.61 (d) 29.72 (m), 31.96 (s), 33.06 (s), 42.00 (d), 51.00 (d),
123.85 (s), 125.21 (d), 126.52 (s), 131.15 (s). Anal. Calcd for
C34H56N3P: C, 75.93; H, 10.50; N, 7.81. Found: C, 75.89; H, 10.63;
N, 7.82. MS (ASAP) m/z: calcd for [C34H57N3P + H+], 538.4290;
found, 538.4298.
C, 75.70; H, 10.55; N, 8.22. MS (ASAP) m/z: calcd for [C32H52N3P +
H+], 510.3977; found, 510.3975.
N,N-Diethyl-1,3-diisopropyl-1,3,2-diazaphospholidin-2-amine
(3a). 2-Chloro-1,3-diisopropyl-1,3,2-diazaphospholidine (569 mg,
2.70 mmol), triethylamine (364 mg, 3.6 mmol), and diethyl ether
(30 mL) are loaded into a scintillation vial. Diethylamine (0.31 mL,
3.0 mol) is added dropwise and allowed to stir for 20 min.
Precipitation of a white solid is observed immediately upon injection.
The solid byproduct is filtered off. A second equivalent of
triethylamine (364 mg, 3.60 mmol) is added followed by the
dropwise addition of diethylamine (0.31 mL, 3.0 mmol) and allowed
to stir for 2 h. The white precipitate is filtered. The resulting deep
orange liquid is used without further purification. Yield 474 mg
1
(71%). 31P{1H} NMR (162 MHz, C6D6): δ 106.40. H NMR (400
MHz, C6D6): δ 1.02 (t, 6H), 1.16 (dd, 12H), 2.80 (m, 2H), 3.05 (m,
6H), 3.35 (m, 2H). 13C{1H} NMR (125 MHz, C6D6): δ 15.08 (d),
21.73 (dd), 39.09 (d), 44.33 (d), 46.94 (d). Anal. Calcd for
C12H28N3P: C, 58.75; H, 11.50; N, 17.31. Found: C, 59.13; H, 11.58;
N, 17.17. MS (ASAP) m/z: calcd for [C12H28N3P + H+], 246.2099;
found, 246.2099.
N,N-Diethyl-1,3-dibenzyl-1,3,2-diazaphospholidin-2-amine (4a).
2-Chloro-1,3-dibenzyl-1,3,2-diazaphospholidine (1.106 g, 3.600 mol),
triethylamine (485 mg, 4.80 mmol), and diethyl ether (20 mL) are
loaded into a scintillation vial. Diethylamine (0.41 mL, 4.0 mmol) is
added dropwise and allowed to stir for 20 min. Precipitation of a
white solid is observed immediately upon injection. The solid
byproduct is filtered off. The resulting orange liquid is used without
further purification. Yield 1.073 g (86%). 31P{1H} NMR (202 MHz,
CDCl3): δ 113.88. 1H NMR (500 MHz, CDCl3): δ 1.08 (t, 6H), 2.90
(m, 2H), 3.09 (quin, 4H), 3.17 (m, 2H), 3.94 (dd, 2H), 4.19 (dd,
2H), 7.26 (m, 2H), 7.35 (m, 8H). 13C{1H} NMR (125 MHz,
CDCl3): δ 15.18 (s), 43.93 (s), 44.58 (d), 48.78 (d), 127.57 (s),
128.12 (s), 128.63 (s). Anal. Calcd for C20H28N3P: C, 70.36; H, 8.27;
N, 12.31. Found: C, 70.27; H, 8.29; N, 12.07. MS (ASAP) m/z: calcd
for [C20H28N3P + H+], 342.2099; found, 342.2110.
N,N-Diethyl-1,3-dioctyl-1,3,2-diazaphospholidin-2-amine (5a).
2-Chloro-1,3-dioctyl-1,3,2-diazaphospholidine (1.106 g, 3.600 mol),
triethylamine (485 mg, 4.80 mmol), and diethyl ether (20 mL) are
loaded into a scintillation vial. Diethylamine (0.41 mL, 4.0 mmol) is
added dropwise and allowed to stir for 2 h. Precipitation of a white
solid is observed immediately upon injection. The solid byproduct is
filtered off. A second equivalent of triethylamine (485 mg, 4.80
mmol) is added followed by the dropwise addition of diethylamine
(0.41 mL, 4.0 mmol) and allowed to stir for 2 h. The white precipitate
is filtered. The resulting pale yellow liquid is used without further
purification. Yield 1.791 g (90%). 31P{1H} NMR (202 MHz, C6D6): δ
113.22. 1H NMR (500 MHz, C6D6): δ 0.90 (t, 6H), 1.03 (t, 6H), 1.29
(m, 20H), 1.59 (m, 4H), 2.92 (m, 6H), 3.07 (quin, 4H), 3.16 (m,
2H). 13C{1H} NMR (125 MHz, C6D6): δ 14.00 (s), 15.17 (s), 22.74
(s), 27.29 (s), 29.54 (d), 29.75 (d), 31.93 (s), 39.20 (d), 48.00 (d),
49.60 (d). Anal. Calcd for C20H28N3P: C, 68.52; H, 12.55; N, 10.90.
Found: C, 68.39; H, 12.51; N, 10.82. MS (ASAP) m/z: calcd for
[C22H49N3P + H+], 386.3664; found, 386.3666.
N-tert-Butyl-1,3-di(2-methylphenyl)-1,3,2-diazaphospholidin-2-
amine (1c). 2-Chloro-1,3-di(2-methylphenyl)-1,3,2-diazaphospholi-
dine (553 mg, 1.80 mmol), triethylamine (242 mg, 2.40 mmol), and
THF (10 mL) are loaded into a scintillation vial. tert-Butylamine
(0.207 mL, 2.00 mmol) is added dropwise and allowed to stir for 20
min. Precipitation of a white solid is observed immediately upon
injection. The solid byproduct is filtered off. Volatiles are removed
from the filtrate, and the resulting solid is recrystallized in THF at
−40 °C to yield a pale yellow solid. Yield: 620 mg (99%). 31P{1H}
1
NMR (202 MHz, CDCl3): δ 87.27. H NMR (500 MHz, CDCl3): δ
0.91 (t, 3H), 1.28 (m, 34H), 2.35 (m, 1H), 2.47 (s, 6H), 2.90 (quin,
2H), 3.39 (m, 2H), 3.89 (m, 2H), 7.05 (t, 2H), 7.24 (m, 7H).
13C{1H} NMR (125 MHz, CDCl3): δ 19.57 (d), 32.78 (d), 49.79 (d),
123.48 (d), 124.75 (d), 126.39 (s), 130.90 (s). Anal. Calcd for
C20H28N3P: C, 70.36; H, 8.27; N, 12.31. Found: C, 70.11; H, 8.38; N,
12.12. MS (ASAP) m/z: calcd for [C20H28N3P + H+], 342.2099;
found, 342.2094.
N,N-Diethyl-1,3-diphenyl-1,3,2-diazaphospholidin-2-amine (2a) is
prepared according to a published procedure on a 3.55 mmol scale.34
Purity is confirmed via 31P, 1H, and 13C NMR spectroscopy. 31P{1H}
1
NMR (202 MHz, CDCl3): δ 95.24. H NMR (500 MHz, CDCl3): δ
0.91 (t, 6H), 3.05 (m, 4H), 3.68 (m, 2H), 3.91 (m, 2H), 6.86 (t, 2H),
7.07 (d, 4H), 7.29 (m, 4H). 13C{1H} NMR (125 MHz, CDCl3): δ
14.25 (s), 39.72 (d), 46.28 (d), 115.05 (d), 118.55 (s), 129.00 (s).
N-Octadecyl-1,3-diphenyl-1,3,2-diazaphospholidin-2-amine
(2b). 2-Chloro-1,3-diphenyl-1,3,2-diazaphospholidine (1.006 g, 3.600
mol), triethylamine (485 mg, 4.80 mmol), and diethyl ether (15 mL)
are loaded into a scintillation vial. Octadecylamine (1.080 g, 4.000
mmol) is dissolved in diethyl ether (5 mL) and added dropwise. The
mixture is allowed to stir for 20 min. Precipitation of a white solid is
observed immediately upon injection. The solid byproduct is filtered
off. Volatiles are removed from the filtrate, and the resulting solid is
recrystallized in THF at −40 °C to yield a pale yellow solid. Yield
1.545 g (83%). 31P{1H} NMR (500 MHz, CDCl3): δ 84.77. 1H NMR
(202 MHz, CDCl3): δ 0.91 (t, 3H), 1.29 (m, 33H), 2.58 (m, 1H),
2.75 (quin, 2H), 3.69 (m, 2H), 3.83 (m, 2H), 6.89 (t, 2H), 7.17 (m,
4H), 7.30 (t, 4H). 13C{1H} NMR (125 MHz, CDCl3): δ 14.16 (s),
22.72 (s), 26.78 (s), 29.23 (s), 29.40 (s), 29.56 (d), 29.72 (m), 31.95
(s), 32.11 (s), 41.48 (s), 46.66 (d), 115.20 (d), 118.81 (s), 129.04
(s). Anal. Calcd for C32H52N3P: C, 75.40; H, 10.28; N, 8.24. Found:
Precursor Conversion Kinetics. A three-neck round-bottom
flask is loaded with indium(III) iodide (112 mg, 0.230 mmol),
zinc(II) chloride (153 mg, 1.13 mmol), and oleylamine (3.659 g,
4.500 mL, 13.70 mmol) and outfitted with a glass adapter for a
temperature probe. The desired phosphorus precursor (0.9 mol of
phosphorus) and trioctylamine (405 mg, 0.500 mL, 1.10 mmol) or
tetraethylene glycol dimethyl ether (in the case of 2a, 504.5 mg,
0.5000 mL, 1.100 mmol) are loaded into a 4 mL vial. Both vessels are
transferred to a Schlenk line and placed under argon. The three-neck
round-bottom flask was brought to the desired temperature, and the 4
mL vial was brought to 100 °C (in some cases to dissolve the
phosphorus precursor). The phosphorus precursor solution was
quickly injected into the mixture of metal salts and allowed to react
for the appropriate amount of time. Quantitative aliquots are taken
sequentially throughout the course of the reaction for analysis by
1
UV−vis and NMR spectroscopy (31P and H).
H
Chem. Mater. XXXX, XXX, XXX−XXX